Sera Prognostics, Inc. - Class A Common Stock (SERA)
2.4900
+0.0400 (1.63%)
NASDAQ · Last Trade: Jul 6th, 12:48 AM EDT
Detailed Quote
Previous Close
2.450
Open
2.440
Bid
2.400
Ask
2.590
Day's Range
2.370 - 2.490
52 Week Range
1.370 - 9.130
Volume
80,123
Market Cap
72.94M
PE Ratio (TTM)
-2.649
EPS (TTM)
-0.9
Dividend & Yield
N/A (N/A)
1 Month Average Volume
823,972
Chart
About Sera Prognostics, Inc. - Class A Common Stock (SERA)
Sera Prognostics Inc is a biotechnology company focused on advancing maternal and fetal health through innovative diagnostic solutions. The company primarily develops predictive tests that aim to assess the risk of pregnancy complications, enabling healthcare providers to offer personalized care and interventions for expectant mothers and their babies. By harnessing advanced biomarker analysis and machine learning technologies, Sera Prognostics seeks to improve pregnancy outcomes and reduce healthcare costs associated with managing high-risk pregnancies. Their commitment to research and collaboration with healthcare professionals highlights their dedication to enhancing the overall well-being of mothers and infants. Read More
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.
The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers during the past week and a look at the reasons why and what's next.
